Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

An epigenomic approach to therapy for tamoxifen-resistant breast cancer.

An epigenomic approach to therapy for tamoxifen-resistant breast cancer. Cell Res. 2014 Jul; 24(7):809-19.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.